ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,670.40
      -2.23%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.06
      0.01%
      Bitcoin
      57,380.10
      -0.65%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Innate Pharma (IPH)

      7. Innate Pharma (IPH) News

      IPH

      Innate Pharma (IPH)

      Innate Pharma
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:IPH
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      07/12/20211:00AMGlobeNewswire Inc.NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021EU:IPHInnate Pharma
      07/12/20211:00AMGlobeNewswire Inc.NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021EU:IPHInnate Pharma
      07/12/20211:00AMGlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021EU:IPHInnate Pharma
      07/12/20211:00AMGlobeNewswire Inc.Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Juillet 2021EU:IPHInnate Pharma
      07/06/20211:00AMGlobeNewswire Inc.Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe PneumoniaEU:IPHInnate Pharma
      07/06/20211:00AMGlobeNewswire Inc.Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe PneumoniaEU:IPHInnate Pharma
      07/06/20211:00AMGlobeNewswire Inc.RESULTATS DE L’ESSAI DE PHASE 2 FORCE, EVALUANT AVDORALIMAB CHEZ LES PATIENTS ATTEINTS D’UNE PNEUMONIE SEVERE DUE AU COVI...EU:IPHInnate Pharma
      06/22/20217:00AMGlobeNewswire Inc.Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis FungoidesEU:IPHInnate Pharma
      06/22/20217:00AMGlobeNewswire Inc.Innate Pharma présente des données préliminaires de l'essai TELLOMAK montrant une réponse clinique avec lacutamab dans le...EU:IPHInnate Pharma
      06/22/20217:00AMGlobeNewswire Inc.Innate Pharma presents preliminary data from TELLOMAK trial showing clinical response for lacutamab in mycosis fungoidesEU:IPHInnate Pharma
      06/16/20211:00AMGlobeNewswire Inc.Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company StrategyEU:IPHInnate Pharma
      06/16/20211:00AMGlobeNewswire Inc.Innate Pharma Présentera les Progres de sa Strategie Lors d'un Événement Virtuel a Destination des InvestisseursEU:IPHInnate Pharma
      06/16/20211:00AMGlobeNewswire Inc.Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company StrategyEU:IPHInnate Pharma
      06/14/20211:00AMGlobeNewswire Inc.Nouveau Nombre D’Actions et de Droits de Vote d’Innate Pharma au 1er Juin 2021EU:IPHInnate Pharma
      06/14/20211:00AMGlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021EU:IPHInnate Pharma
      06/14/20211:00AMGlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021EU:IPHInnate Pharma
      06/10/20211:00AMGlobeNewswire Inc.Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual MeetingEU:IPHInnate Pharma
      06/10/20211:00AMGlobeNewswire Inc.Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual MeetingEU:IPHInnate Pharma
      06/10/20211:00AMGlobeNewswire Inc.Innate Pharma Presentera des Données Issues de sa Plateforme de NK Cell Engagers de Nouvelle Generation au Congrés Annuel d...EU:IPHInnate Pharma
      06/09/20216:00AMGlobeNewswire Inc.New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Mali...EU:IPHInnate Pharma
      06/09/20216:00AMGlobeNewswire Inc.New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Mali...EU:IPHInnate Pharma
      06/09/20216:00AMGlobeNewswire Inc.De Nouvelles Données pour Lacutamab Issues de l'Essai TELLOMAK Seront Partagées Lors d'Une Présentation Orale au 16ème Co...EU:IPHInnate Pharma
      06/09/20216:00AMGlobeNewswire Inc.New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Mali...EU:IPHInnate Pharma
      05/28/20214:01PMGlobeNewswire Inc.Résultats de l’Assemblée Générale d'Innate PharmaEU:IPHInnate Pharma
      05/28/20214:01PMGlobeNewswire Inc.Outcome of Innate Pharma’s Annual General MeetingEU:IPHInnate Pharma
      05/28/20214:01PMGlobeNewswire Inc.Outcome of Innate Pharma’s Annual General MeetingEU:IPHInnate Pharma
      05/25/20211:00AMGlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021EU:IPHInnate Pharma
      05/25/20211:00AMGlobeNewswire Inc.Nouveau Nombre D'Actions et de Droits de Vote d'Innate Pharma au 1er Mai 2021EU:IPHInnate Pharma
      05/25/20211:00AMGlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021EU:IPHInnate Pharma
       Showing the most relevant articles for your search:EU:IPH

      Your Recent History

      LSE
      CPE
      Charter Pan-european Trust
      COIN
      BTTBTC
      Delayed Upgrade Clock